2 Followers on Owler

Israel Biotech Fund

Israel Biotech Fund is an investment firm that invests in biotechnology and pharmaceutical companies. Read more

Yuval Cabilly's photo - Co-Founder of Israel Biotech Fund

Co-Founder

Yuval Cabilly

CEO Approval Rating

- -/100

Founded:

2014

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

ISRAEL BIOTECH FUND TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Trusted Tablets is Israel Biotech Fund's top competitor. Trusted Tablets is headquartered in Larnaca, Larnarca District, and was founded in 2007. Trusted Tablets is in the Pharmaceuticals field. Trusted Tablets generates ∞% the revenue of Israel Biotech Fund.

High Times is seen as one of Israel Biotech Fund's top competitors. High Times's headquarters is in Los Angeles, California, and was founded in 1974. High Times competes in the Publishing industry. High Times generates ∞% of Israel Biotech Fund's revenue.

Ubiquiti has been one of Israel Biotech Fund's top competitors. Ubiquiti was founded in 2003, and its headquarters is in New York, New York. Ubiquiti competes in the Computers, Peripherals, Networking and Electronic Equipment field. Ubiquiti has 1,021 more employees than Israel Biotech Fund.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Vicore Pharma a competitor of Israel Biotech Fund?

Israel Biotech Fund Acquisitions

No recent acquisitions found related to Israel Biotech Fund

Israel Biotech Fund Funding History

Since Israel Biotech Fund was founded in 2014, it has participated in 2 rounds of funding. In total Israel Biotech Fund has raised $112.0M. Israel Biotech Fund's last funding round was on Apr 2021 for a total of $112.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Apr 2021
$112M
-
Investment Fund
Jul 2019
--
-

Since Israel Biotech Fund was founded in 2014, it has participated in 2 rounds of funding. In total Israel Biotech Fund has raised $112.0M. Israel Biotech Fund's last funding round was on Apr 2021 for a total of $112.0M

Israel Biotech Fund Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

SpliSense is an Israel-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cystic fibrosis and genetic pulmonary diseases.
$28.5M
May 12, 2021
Series B
-
BioSight is a pharmaceutical company that focuses on the development of chemotherapy pro-drugs for the treatment of cancer.
$46M
Mar 11, 2020
Series C
Jun 01, 2017
Ayala is a clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$30M
May 27, 2019
Series B
May 08, 2020
Biond is a pharmaceutical company that researches and develops immuno-therapies for oncology and autoimmune diseases.
$17M
Jan 07, 2019
Series B
-
Gamida Cell is a Jerusalem-based biotechnology company that develops and commercializes novel therapeutics for the treatment of blood cancer.
$40M
Jun 18, 2017
Equity
Oct 27, 2018

Israel Biotech Fund News

April 5, 2021CTech

Israel Biotech Fund ready to expand portfolio after closing $112 million second fund

The fund will focus on the investment and formation of Israeli biotech and pharma companies developin... See more »
December 2, 2020Globes

Cancer drug development co Biosight raises $46m

Biosight, based at Airport City near Tel Aviv, is developing innovative cancer therapeutics for hemat... See more »
March 12, 2020FinSMEs

Biosight Secures $19M in Series C Funding

Biosight Ltd., a Airport City, Israel-based...... See more »
July 16, 2019BioPortfolio

Israel Biotech Fund reports first closure of 2nd fund

The volume and extent of the closure was not disclosed but is probably similar to IBF's first fund wh... See more »
May 30, 2019NoCamels

Ayala Pharmaceuticals Secures $30M To Advance Treatment For Anti-Cancer Products

Ayala Pharmaceuticals, an Israeli clinical-stage company that develops medicines for cancers that are... See more »
May 29, 2019PE Hub Network

Ayala Pharmaceuticals inks $30 mln Series B

Wilmington, Delaware and Israel-based Ayala Pharmaceuticals Inc, a clinical-stage company developing ... See more »

Social Media

Israel Biotech Fund Headquarters

Ruhrberg 3 Science Center, Bell Entrance, Pekeris Street, Rabin Science Park 4th Floor

Rehovot, Center District7670212

972-72-2514-175

Driving Directions »

Trending Companies

Israel Biotech Fund Summary

ABOUT

Overview

Israel Biotech Fund is an investment firm that invests in biotechnology and pharmaceutical companies. Israel Biotech Fund was founded in 2014. Israel Biotech Fund's headquarters is located in Rehovot, Center District, IL 7670212. It has raised 112.0M ...

Frequently Asked Questions about Israel Biotech Fund

  1. When was Israel Biotech Fund founded?

    Israel Biotech Fund was founded in 2014
  2. Who is Israel Biotech Fund's CEO?

    Israel Biotech Fund's CEO is Yuval Cabilly
  3. How much revenue does Israel Biotech Fund generate?

    Israel Biotech Fund generates $ < 1M in revenue
  4. How much funding does Israel Biotech Fund have?

    Israel Biotech Fund has historically raised $112M in funding
  1. Where is Israel Biotech Fund's headquarters?

    Israel Biotech Fund's headquarters is in Rehovot Center District, IL
  2. How many employees does Israel Biotech Fund have?

    Israel Biotech Fund has 0 employees
  3. Who are Israel Biotech Fund's competitors?

    Israel Biotech Fund's top competitors are Trusted Tablets, High Times, Ubiquiti
  4. Who has Israel Biotech Fund invested in?

    Israel Biotech Fund's has invested in companies such as SpliSense, BioSight, Ayala Pharmaceuticals, Inc.